{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:13:39Z","timestamp":1789683219224,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","psychiatricnursing.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Psychiatric Nursing"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.apnu.2020.06.002","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T11:10:22Z","timestamp":1591441822000},"page":"194-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["A qualitative study of medication adherence amongst people with schizophrenia"],"prefix":"10.1016","volume":"34","author":[{"given":"Lucinda","family":"Clifford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shona","family":"Crabb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Turnbull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherrie","family":"Galletly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apnu.2020.06.002_bb0005","doi-asserted-by":"crossref","unstructured":"Ascher-Svanum, H., Zhu, B., Faries, D., Lacro, J. P., & Dolder, C. R. (2006). A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. J Clin Psychiatry, 67, 1114\u201323.","DOI":"10.4088\/JCP.v67n0715"},{"key":"10.1016\/j.apnu.2020.06.002_bb0010","doi-asserted-by":"crossref","unstructured":"Barkhof, E., Meijer, C. J., De Sonneville, L. M., Linszen, D. H., & de Haan, L. (2012). Interventions to improve adherence to antipsychotic medication in patients with schizophrenia--a review of the past decade. Eur Psychiatry, 27, 9\u201318.","DOI":"10.1016\/j.eurpsy.2011.02.005"},{"key":"10.1016\/j.apnu.2020.06.002_bb0015","doi-asserted-by":"crossref","unstructured":"Chang, J.G., Roh, D., and Kim, C.H. (2019). Associaiton between therapeutic alliance and adherence in outpatient Schizophrenia patients. Clin Psychopharmacol Neurosci. 17, 273\u2013278.","DOI":"10.9758\/cpn.2019.17.2.273"},{"key":"10.1016\/j.apnu.2020.06.002_bb0020","doi-asserted-by":"crossref","unstructured":"Czobor, P., Van Dorn, R. A., Citrome, L., Kahn, R. S., Fleischhacker, W. W., & Volavka, J. (2015). Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies. Eur Neuropsychopharmacol, 25, 1158\u201366.","DOI":"10.1016\/j.euroneuro.2015.04.003"},{"key":"10.1016\/j.apnu.2020.06.002_bb0025","doi-asserted-by":"crossref","unstructured":"Dixon, L.B., Dickerson, F., Bellack, A.S. et al. (2010). The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull, 36, 48\u201370.","DOI":"10.1093\/schbul\/sbp115"},{"key":"10.1016\/j.apnu.2020.06.002_bb0030","doi-asserted-by":"crossref","unstructured":"Dobber, J., Latour, C., van Meijel et al. (2020). Active ingredients and mechanisms of change in motivational interviewing for medicaiton adherence. A mixed methods study of patient -therapist interaction in patients with schizophrenia. Front. Psychiatry, 11, 78.","DOI":"10.3389\/fpsyt.2020.00078"},{"key":"10.1016\/j.apnu.2020.06.002_bb0035","doi-asserted-by":"crossref","unstructured":"El Khoury, A. C., Pilon, D., Morrison, L., et al. (2020). Projecting The Long - Term Economic Impact of Once Monthly Paliperidone Palmitate Versus Oral Atypical Antipsychotics in Medicaid Patients with Schizophrenia. J Manag Care Spec Pharm, 26 176\u2013185.","DOI":"10.18553\/jmcp.2020.26.2.176"},{"key":"10.1016\/j.apnu.2020.06.002_bb0040","doi-asserted-by":"crossref","unstructured":"Emsley, R., Chiliza, B., Asmal, L., & Harvey, B. H. (2013). The nature of relapse in schizophrenia. BMC Psychiatry, 8, 13: 50.","DOI":"10.1186\/1471-244X-13-50"},{"key":"10.1016\/j.apnu.2020.06.002_bb0045","doi-asserted-by":"crossref","unstructured":"Forsman, J., Taipale, H., Masterman, T. et al. (2019). Adherence to psychotropic medication in completed suicide in Sweden 2006\u20132013: a forensic-toxicological matched case-control study. Pharmacoepidemiology and Prescription, 75, 1421\u20131430.","DOI":"10.1007\/s00228-019-02707-z"},{"key":"10.1016\/j.apnu.2020.06.002_bb0050","doi-asserted-by":"crossref","unstructured":"Gibson, S., Brand, S. L., Burt, S., Boden, Z.V., & Benson, O. (2013). Understanding treatment non-adherence in schizophrenia and bipolar disorder: a survey of what service users do and why. BMC Psychiatry, 29, 13: 153.","DOI":"10.1186\/1471-244X-13-153"},{"key":"10.1016\/j.apnu.2020.06.002_bb0055","unstructured":"Glaser, B. G., & Straus, A.L. (1967). The Discovery of Grounded Theory: Strategies for Qualitative Research. Chicago: Aldine Publishing Company."},{"key":"10.1016\/j.apnu.2020.06.002_bb0060","unstructured":"Hesse-Biber, S. N., & Leavy, P. (2004). Approaches to Qualitative Research: A Reader on Theory and Practice. New York: Oxford University Press."},{"key":"10.1016\/j.apnu.2020.06.002_bb0065","unstructured":"Hesse-Biber SN & Leavy P. (2006). The practice of qualitative research. California: Sage."},{"key":"10.1016\/j.apnu.2020.06.002_bb0070","doi-asserted-by":"crossref","unstructured":"Higashi, K., Medic, G., Littlewood, K. J., Diez, T., Granstrom, O., & De Hert, M. (2013). Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol, 3, 200\u201318.","DOI":"10.1177\/2045125312474019"},{"key":"10.1016\/j.apnu.2020.06.002_bb0075","doi-asserted-by":"crossref","unstructured":"Jonsdottir, H., Opjordsmoen, S., Birkenaes, A.B. et al. (2013). Predictors of medication adherence in patients with schizophrenia and bipolar disorder. Acta Psychiatr Scand, 127, 23\u201333.","DOI":"10.1111\/j.1600-0447.2012.01911.x"},{"key":"10.1016\/j.apnu.2020.06.002_bb0080","doi-asserted-by":"crossref","unstructured":"Kim, J., Ozzoude, M., Nakajima, S. et al. (2020). Insight and medicaiton adherence in schizophrenia. An analysisof the CATIE trial. Neuropharmacology, 168, 107634.","DOI":"10.1016\/j.neuropharm.2019.05.011"},{"key":"10.1016\/j.apnu.2020.06.002_bb0085","doi-asserted-by":"crossref","unstructured":"Kreyenbuhl, J., Record, E. J., & Palmer-Bacon, J. (2016). A review of behavioral tailoring strategies for improving medication adherence in serious mental illness. Dialogues Clin Neurosci 18: 191\u2013201.","DOI":"10.31887\/DCNS.2016.18.2\/jkreyenbuhl"},{"key":"10.1016\/j.apnu.2020.06.002_bb0090","doi-asserted-by":"crossref","unstructured":"Lieberman, J.A., Stroup, T.S., Mcevoy, J.P. et al. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med, 353, 1209\u201323.","DOI":"10.1056\/NEJMoa051688"},{"key":"10.1016\/j.apnu.2020.06.002_bb0095","doi-asserted-by":"crossref","unstructured":"Lincoln, T. M., Wilhelm, K., & Nestoriuc, Y. (2007). Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: a meta-analysis. Schizophr Res, 96, 232\u201345.","DOI":"10.1016\/j.schres.2007.07.022"},{"key":"10.1016\/j.apnu.2020.06.002_bb0110","unstructured":"Maxwell, J.A. (2005). Qualitative Research Design: An Interactive Approach. California: Sage Publications."},{"key":"10.1016\/j.apnu.2020.06.002_bb0115","doi-asserted-by":"crossref","unstructured":"Novick D, Haro JM, Suarez D., Perez, V., Dittmann, R. W., & Haddad, P. M. (2010). Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res, 176, 109\u201313.","DOI":"10.1016\/j.psychres.2009.05.004"},{"key":"10.1016\/j.apnu.2020.06.002_bb0120","doi-asserted-by":"crossref","unstructured":"O'Brien, B. C., Harris, I. B., Beckman, T. J. et al. (2014). Standards for Reporting Qualitative Research: A Synthesis of Recommnedations. Academic Medicine, 9, 1245\u201351.","DOI":"10.1097\/ACM.0000000000000388"},{"key":"10.1016\/j.apnu.2020.06.002_bb0125","unstructured":"Pidgeon, N. (1996). Grounded theory: Theoretical background. In Richardson JTE (Eds.) Handbook of Qualitative Research Methods for Psychology and the Social Sciences. Oxford: Wiley-Blackwell."},{"key":"10.1016\/j.apnu.2020.06.002_bb0130","doi-asserted-by":"crossref","unstructured":"Rogers, A., Day, J. C., Williams, B. et al. (1998). The meaning and management of neuroleptic medication: a study of patients with a diagnosis of schizophrenia. Social Science and Medicine, 47, 1313\u201323.","DOI":"10.1016\/S0277-9536(98)00209-3"},{"key":"10.1016\/j.apnu.2020.06.002_bb0135","doi-asserted-by":"crossref","unstructured":"Salzmann-Erikson, M., & Sjodin, M. (2018). A narrative meta-synthesis of how people with schizophrenia experience facilitators and barriers in using antipsychotic medication: Implications for healthcare professionals. International Journal of Nursing Studies, 85, 718.","DOI":"10.1016\/j.ijnurstu.2018.05.003"},{"key":"10.1016\/j.apnu.2020.06.002_bb0140","doi-asserted-by":"crossref","unstructured":"Sendt, K.V., Tracy, D.K., & Bhattacharyya, S. (2015). A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders. Psychiatry Res, 225, 14\u201330.","DOI":"10.1016\/j.psychres.2014.11.002"},{"key":"10.1016\/j.apnu.2020.06.002_bb0145","doi-asserted-by":"crossref","unstructured":"Stentzel, U., van den Berg, N., Schulze, L.N. et al. (2018) Predictors of medication adherence among patients with seevre psychiatric disorders: findings from the baseline assessment of a randomized controlled trial (Tecla). BMC Psychiatry, 18:155.","DOI":"10.1186\/s12888-018-1737-4"},{"key":"10.1016\/j.apnu.2020.06.002_bb0150","doi-asserted-by":"crossref","unstructured":"Tranulis, C., Goff, D., Henderson, D.C., & Freudenreich, O. (2011). Becoming adherent to antipsychotics: a qualitative study of treatment-experienced schizophrenia patients. Psychiatr Serv, 62, 888\u201392.","DOI":"10.1176\/ps.62.8.pss6208_0888"},{"key":"10.1016\/j.apnu.2020.06.002_bb0155","doi-asserted-by":"crossref","unstructured":"Vandewalle, J., Debyser, B., & Beeckman, D. (2018).Constructing a positive identity: A qualitative study of the driving forces of peer workers in mental health-care systems. Int J of Mental Health Nursing 27, 378\u2013389.","DOI":"10.1111\/inm.12332"},{"key":"10.1016\/j.apnu.2020.06.002_bb0160","doi-asserted-by":"crossref","unstructured":"Velligan, D. I., Weiden, P. J., Sajatovic, M. et al. (2009). The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry, 70, 01\u201348.","DOI":"10.4088\/JCP.7090su1cj"},{"key":"10.1016\/j.apnu.2020.06.002_bb0165","doi-asserted-by":"crossref","unstructured":"Wunderink, L., Nieboer, R. M., Wiersma, D., Sytema, S., & Nienhuis, F. J. (2013). Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction\/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiatry, 70, 913\u201320.","DOI":"10.1001\/jamapsychiatry.2013.19"},{"key":"10.1016\/j.apnu.2020.06.002_bb0170","doi-asserted-by":"crossref","unstructured":"Xia, J., Mi, W., Li, L. et al. (2015). High relapse rate and poor medication adherence in the Chinese population with schizophrenia: Results from an observational survey in the people's republic of China. Neuropsychiatr. Dis. Treat. 11, 1161\u20131167.","DOI":"10.2147\/NDT.S72367"}],"container-title":["Archives of Psychiatric Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883941720300455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883941720300455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:29:07Z","timestamp":1760124547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883941720300455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0883941720300455"],"URL":"https:\/\/doi.org\/10.1016\/j.apnu.2020.06.002","relation":{},"ISSN":["0883-9417"],"issn-type":[{"value":"0883-9417","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A qualitative study of medication adherence amongst people with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Archives of Psychiatric Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apnu.2020.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}